Return On Equity
88%
Trailing 12 months · Through 30 Sep 2022
YoY relative change: +20%
Colambda Technologies, Inc. financial metrics
Period Q3 2022 · Filed 10 Nov 2022
Key metrics snapshot
Return On Assets
11%
Trailing 12 months · Through 30 Sep 2022
Operating Margin
2.8%
Trailing 12 months · Through 30 Sep 2022
Current Ratio
1.52x
Period-end balance · Through 30 Sep 2022
Quick Ratio
1.47x
Period-end balance · Through 30 Sep 2022
Debt-to-equity
18.76x
Period-end balance · Through 30 Sep 2022
YoY relative change: -1976%
Profitability
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
88%
Trailing 12 months · 30 Sep 2022
|
+20% |
| Return On Assets |
11%
Trailing 12 months · 30 Sep 2022
|
|
| Operating Margin |
2.8%
Trailing 12 months · 30 Sep 2022
|
Financial Health
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
1.52x
Period-end balance · 30 Sep 2022
|
|
| Quick Ratio |
1.47x
Period-end balance · 30 Sep 2022
|
|
| Debt-to-equity |
18.76x
Period-end balance · 30 Sep 2022
|
-1976% |
Growth
| Metric | Latest value | YoY relative change |
|---|---|---|
| Revenues |
$5,288,255
Trailing 12 months · 30 Sep 2022
|
Share Metrics
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
79,151,187
Period-end balance · 31 Oct 2022
|
+534% |
| Common Stock, Shares, Outstanding |
129,176,724
Period-end balance · 30 Sep 2022
|
+935% |
| Common Stock, Value, Issued |
$129,177
Period-end balance · 30 Sep 2022
|
+935% |
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accounts Receivable, after Allowance for Credit Loss, Current |
$2,619,580
Period-end balance · 30 Sep 2022
|
|
| Additional Paid in Capital |
$1,251,331
Period-end balance · 30 Sep 2022
|
-29% |
| Assets |
$2,932,696
Period-end balance · 30 Sep 2022
|
|
| Assets, Current |
$2,898,696
Period-end balance · 30 Sep 2022
|
|
| Cash and Cash Equivalents, at Carrying Value |
$188,974
Period-end balance · 30 Sep 2022
|
-74% |
| Common Stock, Par or Stated Value Per Share |
0
Period-end balance · 30 Sep 2022
|
0% |
| Common Stock, Shares Authorized |
200,000,000
Period-end balance · 30 Sep 2022
|
0% |
| Common Stock, Shares, Issued |
129,176,724
Period-end balance · 30 Sep 2022
|
+935% |
| General and Administrative Expense |
$146,924
Trailing 12 months · 30 Sep 2022
|
+409% |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
$161,750
Trailing 12 months · 30 Sep 2022
|
|
| Income Tax Expense (Benefit) |
$0
Trailing 12 months · 30 Sep 2022
|
|
| Interest Expense |
-$14,458
Trailing 12 months · 30 Sep 2022
|
-175% |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$6,782
Period-end balance · 30 Sep 2022
|
|
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$29,895
Period-end balance · 30 Sep 2022
|
|
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$28,512
Period-end balance · 30 Sep 2022
|
|
| Liabilities |
$2,282,449
Period-end balance · 30 Sep 2022
|
+713% |
| Liabilities and Equity |
$2,932,696
Period-end balance · 30 Sep 2022
|
|
| Liabilities, Current |
$1,912,484
Period-end balance · 30 Sep 2022
|
|
| Operating Income (Loss) |
$147,291
Trailing 12 months · 30 Sep 2022
|
|
| Operating Lease, Liability |
$19,886
Period-end balance · 30 Sep 2022
|
|
| Operating Lease, Liability, Noncurrent |
$60,075
Period-end balance · 30 Sep 2022
|
|
| Operating Lease, Right-of-Use Asset |
$58,693
Period-end balance · 30 Sep 2022
|
|
| Operating Lease, Weighted Average Discount Rate, Percent |
0.07
Period-end balance · 30 Sep 2022
|
|
| Operating Leases, Future Minimum Payments Due |
$65,190
Period-end balance · 30 Sep 2022
|
|
| Other Assets, Current |
$13,738
Period-end balance · 30 Sep 2022
|
|
| Preferred Stock, Par or Stated Value Per Share |
0
Period-end balance · 30 Sep 2022
|
0% |
| Preferred Stock, Shares Authorized |
50,000,000
Period-end balance · 30 Sep 2022
|
0% |
| Preferred Stock, Shares Issued |
0
Period-end balance · 30 Sep 2022
|
|
| Property, Plant and Equipment, Net |
$46,000
Period-end balance · 30 Sep 2022
|
|
| Research and Development Expense |
$0
Reported period · 30 Sep 2022
|
-100% |
| Retained Earnings (Accumulated Deficit) |
-$730,261
Period-end balance · 30 Sep 2022
|
+64% |
| Stockholders' Equity Attributable to Parent |
$650,247
Period-end balance · 30 Sep 2022
|
Comparisons, sources and research notes
Sources and sharing
Colambda Technologies, Inc. Financial Facts
- Context
- Latest metrics period: Q3 2022
- Latest reported value
- Return On Equity 88%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q3 2022
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q3 2022.
- Most recent SEC facts end date on this page: 31 Oct 2022.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for Colambda Technologies, Inc.
Latest financial period: Q3 2022. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
10 Nov 2022
Page type
Company facts
Latest period
Q3 2022
SEC-backed company facts were refreshed from filings filed on 10 Nov 2022.
Benchmark Context
How Return On Equity compares
Return On Equity is up about 20% versus the comparable prior period.
Compared with
Compared with Colambda Technologies, Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
- Latest comparable period on this page: Q3 2022.
- Peer context will appear when enough companies report a comparable value for this metric.
- Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Filing notes and source
Key facts
- Colambda Technologies, Inc. financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q3 2022.
- Headline metric: Return On Equity 88%.
Change
- Return On Equity YoY relative change: +20%.
- Most recent SEC facts end date: 31 Oct 2022.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2022-10-31) highlights Return On Equity 87.6%, Return On Assets 11.0%, and Operating Margin 2.8%.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
No market comparison
USD inputs only. Cash and complete debt must share the latest balance date. Missing balances are unknown, never zero; equity value and market EV remain unavailable until both are verified.
DCF estimate is unavailable because required valuation inputs are missing.
Missing: Free cash flow.
Input periods, units and SEC sources
Equity value = DCF enterprise value + cash − debt. Cash flow uses matching annual or trailing-12-month periods.
- Operating cash flow: -652,955.0 USD · through 2022-09-30 · prior annual + current YTD − prior YTD SEC source SEC source SEC source
- Capital expenditures: unavailable on a verified comparable basis
- Cash and equivalents: 188,974.0 USD · through 2022-09-30 SEC source
- Debt: unavailable on a verified comparable basis
Data confidence notes
- Free cash flow unavailable: matching usd annual or trailing-12-month operating cash flow and cash capex are required
- Debt unavailable: no complete usd debt balance at the latest balance date
- Ticker missing for issuer
- Valuation unavailable: free cash flow is missing
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
75.0/100
Balanced Confidence medium
Return On Equity
88%
Metric score 100.0/100
Return On Assets
11%
Metric score 100.0/100
Financial Health
- Current Ratio
- 1.52x
- Quick Ratio
- 1.47x
- Debt to Equity
- 18.76x
Strengths
Return On Equity, Return On Assets, and Current Ratio
Watchpoints
Operating Margin and Debt-to-equity
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first